- Home
- UNFI vs NAMS Comparison
UNFI vs NAMS Comparison
Compare UNFI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNFI
- NAMS
- Stock Information
- Founded
- UNFI 1976
- NAMS 2019
- Country
- UNFI United States
- NAMS Netherlands
- Employees
- UNFI N/A
- NAMS N/A
- Industry
- UNFI Food Distributors
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- UNFI Consumer Discretionary
- NAMS Health Care
- Exchange
- UNFI Nasdaq
- NAMS Nasdaq
- Market Cap
- UNFI 1.7B
- NAMS 1.7B
- IPO Year
- UNFI 1996
- NAMS N/A
- Fundamental
- Price
- UNFI $27.99
- NAMS $26.52
- Analyst Decision
- UNFI Hold
- NAMS Strong Buy
- Analyst Count
- UNFI 7
- NAMS 6
- Target Price
- UNFI $21.08
- NAMS $36.20
- AVG Volume (30 Days)
- UNFI 839.1K
- NAMS 1.4M
- Earning Date
- UNFI 12-10-2024
- NAMS 02-06-2025
- Dividend Yield
- UNFI N/A
- NAMS N/A
- EPS Growth
- UNFI N/A
- NAMS N/A
- EPS
- UNFI N/A
- NAMS N/A
- Revenue
- UNFI $31,299,000,000.00
- NAMS $33,594,000.00
- Revenue This Year
- UNFI $1.15
- NAMS $129.49
- Revenue Next Year
- UNFI $0.92
- NAMS N/A
- P/E Ratio
- UNFI N/A
- NAMS N/A
- Revenue Growth
- UNFI 3.32
- NAMS 78.77
- 52 Week Low
- UNFI $8.58
- NAMS $10.29
- 52 Week High
- UNFI $32.20
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- UNFI 66.96
- NAMS 68.38
- Support Level
- UNFI $27.23
- NAMS $24.40
- Resistance Level
- UNFI $28.27
- NAMS $27.29
- Average True Range (ATR)
- UNFI 1.18
- NAMS 1.57
- MACD
- UNFI 0.14
- NAMS 0.63
- Stochastic Oscillator
- UNFI 50.64
- NAMS 94.52
About UNFI United Natural Foods Inc.
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.